cgp 28392 has been researched along with nitrendipine in 14 studies
| Studies (cgp 28392) | Trials (cgp 28392) | Recent Studies (post-2010) (cgp 28392) | Studies (nitrendipine) | Trials (nitrendipine) | Recent Studies (post-2010) (nitrendipine) |
|---|---|---|---|---|---|
| 76 | 1 | 2 | 2,170 | 378 | 83 |
| Protein | Taxonomy | cgp 28392 (IC50) | nitrendipine (IC50) |
|---|---|---|---|
| G-protein coupled receptor 55 | Homo sapiens (human) | 1.4652 | |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | 0.0152 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.3 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Rattus norvegicus (Norway rat) | 0.0013 | |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Rattus norvegicus (Norway rat) | 0.0013 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 3 | |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | 0.0152 | |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Rattus norvegicus (Norway rat) | 0.0013 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 10 | |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | 0.0152 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 0.0152 | |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | 1.85 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (71.43) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frank, GB | 1 |
| Akimoto, T; Ariyoshi, S; Fujisue, T; Ichida, S; Wada, T | 1 |
| Criscione, L; Meier, M; Rogg, H; Truog, A | 1 |
| Carpenter, CL; Greenberg, DA; Messing, RO | 1 |
| Aunis, D; Gandía, L; García, AG; Ladona, MG | 1 |
| Plant, TD | 2 |
| Montague, W; Morgan, NG; Rumford, GM; Short, CD | 1 |
| Bühler, FR; Erne, P; Resink, TJ | 1 |
| Groth, H; Locher, R; Neyses, L; Stimpel, M; Vetter, W | 1 |
| Freedman, SB; Miller, RJ | 1 |
| Bühler, FR; Bürgisser, E; Dubach, B; Erne, P; Kühnis, H; Meier, M; Rogg, H | 1 |
| Caviedes, P; Caviedes, R; Jaimovich, E; Olivares, E; Salas, K | 1 |
| Chaylakhyan, LM; Grishchenko, VM; Zherelova, OM | 1 |
14 other study(ies) available for cgp 28392 and nitrendipine
| Article | Year |
|---|---|
Dihydropyridine calcium channel antagonists block and agonists potentiate high potassium contractures but not twitches in frog skeletal muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; In Vitro Techniques; Muscle Contraction; Nifedipine; Nitrendipine; Potassium; Pyridines; Rana pipiens | 1990 |
Effects of calcium channel agonists (BAY K 8644, CGP28392 and YC-170) on 45Ca uptake by rat uterine segments.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channels; Female; Nifedipine; Nitrendipine; Potassium Chloride; Pyridines; Rats; Rats, Inbred Strains; Uterus | 1991 |
In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding, Competitive; Biological Transport; Calcium; Guinea Pigs; Heart Rate; In Vitro Techniques; Ion Channels; Male; Mesentery; Myocardial Contraction; Nifedipine; Nitrendipine; Pyridines; Rats; Vasoconstriction | 1985 |
Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Blockers; Cells, Cultured; Isradipine; Kinetics; Membrane Potentials; Nifedipine; Nitrendipine; Onium Compounds; Organophosphorus Compounds; Oxadiazoles; Potassium; Pyridines; Tritium | 1986 |
Dihydropyridine modulation of the chromaffin cell secretory response.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Cats; Cell Membrane Permeability; Chromaffin Granules; Chromaffin System; Female; Male; Muscarine; Nicotine; Nitrendipine; Norepinephrine; Perfusion; Potassium; Pyridines | 1987 |
Ion channels in pancreatic B cells.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Calcium Channels; Cell Membrane; Cell Membrane Permeability; Ion Channels; Islets of Langerhans; Membrane Potentials; Mice; Nitrendipine; Potassium Channels; Pyridines; Sodium Channels | 1989 |
Properties and calcium-dependent inactivation of calcium currents in cultured mouse pancreatic B-cells.
Topics: Action Potentials; Animals; Barium; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Egtazic Acid; Islets of Langerhans; Membrane Potentials; Mice; Nitrendipine; Pyridines; Sodium; Time Factors | 1988 |
Effects of the calcium-channel agonist CGP 28392 on insulin secretion from isolated rat islets of Langerhans.
Topics: Animals; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Nifedipine; Nitrendipine; Norepinephrine; Pyridines; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1985 |
The influence of CGP 28392, a 1,4-dihydropyridine, on human platelet calcium and cyclic AMP metabolism.
Topics: Alprostadil; Blood Platelets; Calcium; Calcium Channel Blockers; Cyclic AMP; Humans; In Vitro Techniques; Kinetics; Nifedipine; Nitrendipine; Phosphorylation; Protein Kinases; Pyridines | 1985 |
Human red blood cells--an ideal model system for the action of calcium agonists and antagonists.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Erythrocytes; Humans; Ion Channels; Nicardipine; Nifedipine; Nitrendipine; Pyridines; Stimulation, Chemical; Verapamil | 1984 |
Calcium channel activation: a different type of drug action.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Cadmium; Calcium; Calcium Channel Blockers; Cell Line; Diltiazem; Gallopamil; Glioma; Hybrid Cells; Ion Channels; Kinetics; Mice; Neuroblastoma; Nifedipine; Nitrendipine; Pyridines; Rats | 1984 |
Enhancement of calcium influx in human platelets by CGP 28392, a novel dihydropyridine.
Topics: Animals; Blood Platelets; Calcium; Calcium Channel Blockers; Cell Membrane; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Ion Channels; Myocardium; Nifedipine; Nitrendipine; Pyridines | 1984 |
Calcium fluxes, ion currents and dihydropyridine receptors in a new immortal cell line from rat heart muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channels; Calcium Channels, L-Type; Cell Differentiation; Cell Division; Cell Line; Heart; Immunohistochemistry; Male; Membrane Potentials; Muscle Proteins; Myocardium; Nitrendipine; Pyridines; Rats; Rats, Inbred F344; Time Factors; Tritium | 1993 |
Blockers of Ca2+ channels in the plasmalemma of perfused Characeae cells.
Topics: Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cell Membrane; Chlorophyta; Dihydropyridines; Membrane Potentials; Nifedipine; Nitrendipine; Perfusion; Pyridines | 1994 |